Medicus Pharma LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE: Medicus Pharma CEO Discloses 5.3% Stake
Dr. Raza Bokhari, CEO of Medicus Pharma Ltd., has disclosed beneficial ownership of approximately 5.3% of the company's common shares through direct holdings and an investment entity.